Matthew Hammond
Chief Financial Officer, POINT Biopharma Global Inc.
Companies
- Research Alliance Corp IVBoard member Jul 10, 2026 to now1
- Research Alliance Corp IVChief executive officer Jul 10, 2026 to now1
- Research Alliance Corp IIIBoard member May 19, 2026 to now2
- Research Alliance Corp IIIChief executive officer May 19, 2026 to now2
- Research Alliance Corp. IIBoard member Mar 17, 2021 to Mar 17, 20213
- Research Alliance Corp. IIChief Investment Officer Mar 17, 2021 to Mar 17, 20213
- POINT Biopharma Global Inc.Board member Jul 7, 2020 to Jul 7, 20204
- POINT Biopharma Global Inc.Chief financial officer Jul 7, 2020 to Jul 7, 20204
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Research Alliance Corp IV RACD275,000 shares5$3.0M at $10.76Jul 14, 2026
- Research Alliance Corp III RACC275,000 shares6$2.8M at $10.16May 21, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 14, 2026Granted 275,000 shares at $10.00 of Research Alliance Corp IV5
- May 21, 2026Granted 275,000 shares at $10.00 of Research Alliance Corp III6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6